Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Tiam1/Rac1 complex controls Il17a transcription and autoimmunity.
Corrigendum.
IL4I1 augments CNS remyelination and axonal protection by modulating T cell driven inflammation.
Efficient presentation of myelin oligodendrocyte glycoprotein peptides but not protein by astrocytes from HLA-DR2 and HLA-DR4 transgenic mice.
Changing EDSS Progression in Placebo Cohorts in Relapsing MS: A Systematic Review and Meta-Regression.
Protein Citrullination: A Proposed Mechanism for Pathology in Traumatic Brain Injury.
Bone And Soft Tissue Changes In Patients With Spinal Cord Injury And Multiple Sclerosis.
Sphingosine-1-Phosphate (S1P) and S1P Signaling Pathway: Therapeutic Targets in Autoimmunity and Inflammation.
Cutaneous and Mixed Nerve Silent Period Recordings in Symptomatic Paroxysmal Kinesigenic Dyskinesia.
Glutamate signalling: A multifaceted modulator of oligodendrocyte lineage cells in health and disease.
Is Season of Birth Important for Multiple Sclerosis Risk?
[Cell depletion and myoablation for neuroimmunological diseases].
The association between IgG and IgM antibodies against cardiolipin, β2-glycoprotein I and Domain I of β2-glycoprotein I with disease profile in patients with multiple sclerosis.
Description of the Characteristics of Multiple Sclerosis Patients in the Region of Valencia (Spain) Who Requested Treatment with Disease-Modifying Drugs during the 2005-2014 Decade.
[Endogenous retroviruses are associated with autoimmune diseases].
Decreased arylesterase activity of paraoxonase-1 (PON-1) might be a common denominator of neuroinflammatory and neurodegenerative diseases.
Loss of Myelin Basic Protein Function Triggers Myelin Breakdown in Models of Demyelinating Diseases.
Nerve conduction velocity in CMT1A: what else can we tell?
Relapsed Acute Lymphoblastic Leukemia Presenting as Optic Neuritis.
[Effect of axonal developmental disorders in the corpus callosum on the neurological function after birth in septic neonatal rats].
[Diagnostics and treatment of trigeminal neuralgia].
Analysis of multiple sclerosis patients with electrophysiological and structural tests.
Longitudinal diffusion tensor imaging of the rat brain after hexachlorophene exposure.
Pathology and MRI: exploring cognitive impairment in MS.
Automated multi-objective calibration of biological agent-based simulations.
Pages
« first
‹ previous
…
814
815
816
817
818
819
820
821
822
…
next ›
last »